Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.

MLA

Moser, Carlee B., et al. “Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.” Journal of Infectious Diseases, vol. 288, Sept. 2023, pp. S101–10. EBSCOhost, https://doi.org/10.1093/infdis/jiad285.

APA

Moser, C. B., Chew, K. W., Giganti, M. J., Li, J. Z., Aga, E., Ritz, J., Greninger, A. L., Javan, A. C., Ignacio, R. B., Daar, E. S., Wohl, D. A., Currier, J. S., Eron, J. J., Smith, D. M., Hughes, M. D., & Team, for the A.-2/A5401 S. (2023). Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. Journal of Infectious Diseases, 288, S101–S110. https://doi.org/10.1093/infdis/jiad285

Chicago

Moser, Carlee B, Kara W Chew, Mark J Giganti, Jonathan Z Li, Evgenia Aga, Justin Ritz, Alexander L Greninger, et al. 2023. “Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.” Journal of Infectious Diseases 288 (September): S101–10. doi:10.1093/infdis/jiad285.